Adare has a global manufacturing footprint, capable of serving markets throughout the world. From our state-of-the-art facilities in the US and Europe, we can provide development-scale through commercial-scale production. Adare offers a continuum of highly specialized manufacturing services and capabilities to meet your oral solid dose needs.

  • Vandalia, Ohio

    Key Facts:

    179,000 sq ft facility

    R&D center

    Commercial scale manufacturing

    Organic solvent capabilities

    Manufacturing Permit for DEA Schedules II-V

  • San Giuliano (Milan), Italy

    Key Facts:

    93,000 sq ft facility

    Commercial scale manufacturing

    Focused on controlled release technologies

    Organic solvent capabilities

    Tablet & capsule filling

  • Pessano (Milan), Italy

    Key Facts:

    220,000 sq ft facility

    Expanded R&D capabilities

    Clinical & commercial scale manufacturing

    Organic solvent capabilities

    Controlled substances

     

  • Lenexa, Kansas

    Key Facts:

    5,616 sq ft facility

    R&D center

    Non-GMP development scale

    Long-acting injectables

  • Aurora, Illinois

    Key Facts:

    33,000 sq ft facility

    R&D center

    Commercial scale manufacturing

    Fluid bed technology center

    Manufacturing Permit for DEA Schedules II-V

  • Philadelphia, PA (Orthodox)

    Key Facts:

    128,000 sq ft facility

    R&D center

    Commercial scale manufacturing

    High potency manufacturing site

    Manufacturing Permit for DEA Schedules II-IV

     

  • Philadelphia, PA (Dungan)

    Key Facts:

    175,000 sq ft facility

    Packaging & Warehousing

    4 packaging lines & 1 powder filling line

    Packaging of DEA Schedules III-IV